Previous 10 | Next 10 |
2023-05-11 22:54:08 ET Applied DNA Sciences, Inc. (APDN) Q2 2023 Results Earnings Conference Call May 12, 2023, 04:30 PM ET Company Participants Sanjay Hurry - Head of Investor Relations Beth Jantzen - Chief Financial Officer James Hayward - Chairman, President a...
2023-05-11 16:13:10 ET Applied DNA Sciences press release ( NASDAQ: APDN ): Q2 GAAP EPS of $0.05 beats by $0.25 . Revenue of $4.41M (-28.2% Y/Y) beats by $0.28M . For further details see: Applied DNA Sciences GAAP EPS of $0.05 beats by $0.25, revenue of $...
- linearDNA ™ Gaining Momentum as a Differentiated DNA Template for mRNA Production, Company Identifies Early Development-Stage Acquisition Target to Potentially Expand Commercial Advantages - - Balance of CY23 Set Up for Multiple Value Inflection Points - - Conference Call/...
2023-05-10 17:35:36 ET Applied DNA Sciences ( NASDAQ: APDN ) is scheduled to announce FQ2 earnings results on Thursday, May 11th, after market close. The consensus EPS Estimate is -$0.20 and the consensus Revenue Estimate is $4.13M. Over the last 3 months, EPS estimate...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thur...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in PCR-based DNA technologies, announced that its CertainT® supply chain traceability platform is featured in an article on the home page of the New York Times website today. The article, titled "How A.I. and DNA A...
2023-03-29 09:41:18 ET Applied DNA Sciences ( NASDAQ: APDN ) stock rose ~4% after the company said it manufactured and shipped a multi-gram quantity of linearDNA in under six weeks. The quantity was produced by the company's LinearDNA platform under a recurring purchas...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it has established a new high bar for the production of DNA with the manufacture and shipment of a multi-gram quantity of linearDNA™ in under six weeks....
2023-03-22 11:09:24 ET Applied DNA Sciences ( NASDAQ: APDN ) stock rose ~11% on Wednesday after the company said its unit Applied DNA Clinical Labs (ADCL) submitted a validation package to the New York State Department of Health (NYSDOH) seeking approval of...
- Expansion of Population-Scale Molecular Diagnostics Menu Positions ADCL Subsidiary for Long-Term Growth - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subs...
News, Short Squeeze, Breakout and More Instantly...
Applied DNA Sciences Inc. Company Name:
APDN Stock Symbol:
NASDAQ Market:
Applied DNA Sciences Inc. Website:
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (DLA) exercised the first one-year option period of a three-year base contract with two one-year...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability - - Applied DNA Secures Commercial Linea RNAP Quantity Sufficient to Support Anticipated Near-Term Demand - STONY BROOK, NY AND JUPITER, FL / ACCES...